What is the safest topical antibiotic and dosing regimen to prevent infection without impairing graft take in a patient undergoing split‑thickness or full‑thickness skin graft?

Topical Antibiotic Selection for Skin Grafts

For split-thickness and full-thickness skin grafts, bismuth tribromophenate (Xeroform) is the safest and most effective topical agent, applied as a single layer directly to the graft surface and left undisturbed for 5 days, achieving 98.5% graft take without infection. 1

Primary Recommendation: Xeroform-Based Dressing Protocol

• Apply one layer of Xeroform (fine-mesh gauze impregnated with bismuth tribromophenate) directly to the graft surface immediately after placement 1
• Cover with layers of dry coarse-mesh gauze and leave the entire dressing intact until postoperative day 5 1
• This protocol achieved mean graft take of 98.54% ± 0.72% in 142 grafts across 100 patients with burns ranging from 0.5% to 60% total body surface area 1
• No topical antimicrobial solutions or frequent dressing changes are required, which minimizes nursing time and patient discomfort 1

Why Xeroform Over Traditional Antimicrobial-Soaked Dressings

• Traditional methods using multiple layers of gauze with frequent applications of aqueous antimicrobial solutions are unnecessary and labor-intensive compared to the single-layer Xeroform approach 1
• The bismuth tribromophenate in Xeroform provides adequate antimicrobial coverage while maintaining appropriate moisture balance at the wound-graft interface 1
• Leaving dressings intact for 5 days prevents mechanical disruption of the graft during the critical early integration phase 1

Alternative Occlusive Drainage System

• An occlusive drainage system (closed dressing with drainage capability) is a reasonable alternative that provides equivalent graft take rates with significantly less pain compared to conventional saline-moistened gauze methods 2
• This approach causes less pain during dressing changes and provides greater patient satisfaction without compromising graft survival 2
• No wound infections developed in either the occlusive drainage or conventional groups, suggesting both methods provide adequate infection control 2

Critical Infection Prevention Considerations

High-Risk Wound Beds Requiring Enhanced Vigilance

• Vascular ulcers have the highest infection-related graft loss rate at 58.3%, followed by burns at 47.4% 3
• Traumatic tissue defects (16.7%) and flap donor sites (13.5%) have lower infection-related loss rates 3
• Pseudomonas aeruginosa is the most common pathogen causing graft loss (58.1% of infections) and results in more fulminant infections requiring 4.2 times higher reoperation rates 3

Graft-Specific Risk Factors

• Full-thickness grafts are more resistant to infection than split-thickness grafts 3
• Grafts applied to lower extremities or at multiple sites have higher infection rates 3
• Overall infection-related graft loss occurs in approximately 23.5% of cases in general plastic surgery populations 3

Preoperative Antimicrobial Prophylaxis

• For clean surgical procedures involving skin grafting, a single dose of cefazolin (first-generation cephalosporin) administered perioperatively is reasonable 4, 5
• This reduces surgical site infections from 6.8% to 0.9% (p<0.001) in clean vascular surgery 5
• Weight-based cephalosporins should be administered fewer than 60 minutes before skin incision, with redosing for cases longer than 4 hours 4

What NOT to Do: Common Pitfalls

• Do not use topical antimicrobial dressings routinely - they provide no proven benefit and may increase costs without improving outcomes 4
• Avoid frequent dressing changes in the first 5 days - mechanical disruption impairs graft integration 1
• Do not use vancomycin for routine perioperative prophylaxis - insufficient data supports its use 4, 5
• Avoid saline-moistened gauze requiring frequent rewetting - this increases pain and nursing burden without improving graft take 2

Postoperative Wound Care Beyond Day 5

• After initial dressing removal at day 5, evaluate graft take percentage and presence of subgraft fluid 1
• Continue evaluations every other day through day 10 to monitor for delayed complications 1
• Maintain wound moisture and control exudate, but avoid topical antimicrobial agents 4
• Consider adjunctive measures like ice pack application to the donor site for pain control, which significantly reduces pain scores without affecting healing 6

When to Escalate Care

• If signs of infection develop (erythema, purulent drainage, graft non-adherence), obtain wound cultures immediately 3
• Pseudomonas infections require aggressive management given their association with fulminant graft loss 3
• For established infections, surgical debridement is more important than antibiotics alone 4